The US Food and Drug Administration (FDA) has cleared OcuSciences’ retinal health assessment device, the OcuMet Beacon.

Neurogen Biomarking has announced a collaboration with NeuroX to support patients’ journey on its brain health care ecosystem ...

Hilo (formerly known as Aktiia), has raised $42m in an oversubscribed Series B funding round, bringing its total funding to ...

Health technology company Resmed has acquired the software-enabled independent diagnostic testing facility (IDTF), VirtuOx.

The US FDA has approved Element Science’s premarket approval (PMA) application for its Jewel Patch Wearable Cardioverter ...

The FDA has approved Edwards Lifesciences' SAPIEN 3 TAVR platform for the treatment of patients with asymptomatic severe ...

Canada’s UHN and U of T researchers have created a skin-based test that identifies progressive supranuclear palsy (PSP) ...

GE HealthCare is expecting its 2025 revenues to take a hit of around $500m due to the Trump administration’s imposition of ...

The London Cancer Hub has been identified as a key district for ‘frontier innovation’ by London Mayor Sadiq Khan.

HeartBeam’s synthesised 12-lead ECG has met the clinical endpoints in the VALID-ECG pivotal study, assessing ...

LuxIA, an AI algorithm co-developed by RetinAI US and FVS, has achieved CE-MDR certification for diabetic retinopathy (DR) ...

CAD and Microsoft to incorporate a suite of AI-powered mammography solutions into ProFound Breast Health Suite on the ...